-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Sage Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2013 to 2023.
- Sage Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $336K, a 4.03% increase year-over-year.
- Sage Therapeutics, Inc. annual Depreciation for 2023 was $1.39M, a 24.2% increase from 2022.
- Sage Therapeutics, Inc. annual Depreciation for 2022 was $1.12M, a 73.2% decline from 2021.
- Sage Therapeutics, Inc. annual Depreciation for 2021 was $4.18M, a 59% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)